products

Veterinary Medicine Api Enrofloxacin Soluble Powder 93106 60 6 HPLC Approved

Basic Information
Place of Origin: Shaanxi, China
Brand Name: Accenturebio
Certification: GMP, ISO, SGS, QS, HALAL, HPLC
Model Number: Accenture-Enrofloxacin
Minimum Order Quantity: 25kg
Price: $28-$37 per kilogram
Packaging Details: 1-25kg bag, 25kg drum
Delivery Time: 1-3 work days
Payment Terms: T/T, Western Union, MoneyGram
Supply Ability: 5300 kg per month
Detail Information
Product Name: Enrofloxacin EINECS No.: 93106-60-6
Cas No.: 618-911-2 Appearance: Off-white To Light Yellow Powder
COA: Available Brand: Accenturebio
Function: Antibacterial Drugs Place Of Origin: Shaanxi, China
High Light:

ciprofloxacin urinary tract infection

,

neomycin sulfate powder


Product Description

Veterinary Medicine Api Enrofloxacin Soluble Powder 93106 60 6 HPLC Approved

Enrofloxacin Introduction:

Product Name: Enrofloxacin
Cas No.: 93106-60-6
Quality Standard: CPV, BP, EP, USP

Appearance: Off-white to Light yellow powder
MF: C19H22FN3O3
MW: 359.40
Solubility: Soluble in chloroform. Slightly soluble in water. Also soluble in dilute KOH
Shelf Life: 2 years

 

Enrofloxacin is a broad spectrum bactericidal drugs, which has special effects on mycoplasma.
And Enrofloxacin also has ntiseptic effect on escherichia coli, klebsiella bacillus coli, pseudomonas aeruginosa, salmonella, deformation, haemophilus, kill, pasteurella, streptococcus hemolytic pap coli, s. aureus bacteria and so on.
Enrofloxacin can be used as veterinary medicines. It has a long half-time in animals and good dispersion degree, which belongs to the broad spectrum of antibacterial agent.Enrofloxacin 10% Oral Solution (veterinary medicine for poultry) Enrofloxacin

Enrofloxacin Function

1. Ciprofloxacin is used to treat a wide variety of infections, including infections of bones and joints, endocarditis,gastroenteritis, malignant otitis externa, respiratory tract infections, cellulitis, urinary tract infections,prostatitis, anthrax, and chancroid;

2. Ciprofloxacin only treats bacterial infections; it does not treat viral infections such as the common cold. For certain uses including acute sinusitis, lower respiratory tract infections and uncomplicated gonorrhea, ciprofloxacin is not considered a first-line agent;

3. Ciprofloxacin occupies an important role in treatment guidelines issued by major medical societies for the treatment of serious infections, especially those likely to be caused by Gram-negative bacteria, including Pseudomonas aeruginosa.

For example, ciprofloxacin in combination with metronidazole is one of several first-line antibiotic regimens recommended by the Infectious Diseases Society of America for the treatment of community-acquired abdominal infections in adults.It also features prominently in treatment guidelines for acute pyelonephritis, complicated or hospital-acquired urinary tract infection, acute or chronic prostatitis,certain types of endocarditis, certain skin infections, and prosthetic joint infections.

Enrofloxacin Application:

1. Dogs and Cats

The product is indicated in the treatment of bacterial infections of the alimentary, respiratory and urogenital tracts, skin, secondary wound infections and otitis externa where clinical experience, supported where possible by sensitivity testing of the causal organism. 

2. Cattle

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and secondary bacterial infections subsequent to viral conditions (e.g. viral pneumonia) where clinical experience, supported where possible by sensitivity testing of the causal organism.

3. Pigs

Diseases of the respiratory and alimentary tract of bacterial or mycoplasmal origin (e.g. pasteurellosis, actinobacillosis, mycoplasmosis, coli-bacillosis, coli-septicaemia and salmonellosis) and mulifactorial diseases such as atrophic rhinitis and enzootic pneumonia, where clinical experience, supported where possible by sensitivity testing of the causal organism, indicates enrofloxacin as the drug of choice.

Enrofloxacin Specification:

PRODUCT NAME Enrofloxacin
CAS no. 93106-60-6 Quantity 560kgs
Storage Sealed and kept in a dry place,Low temperature
Items of analysis Specification Results
Appearance Yellowish or light orange yellow crystalline powder Complies
Melting point 221℃~226℃ 223.5℃~225.5℃
Identification IR Complies
  HPLC Complies
Appearance of solution Solution is clear, solution is not more intensely colored than reference solution Complies
Fluoroquinolonic acid ≤0.2% <0.2%
Related substances Ciprofloxacin ≤0.5% 0.06%
  Other individual impurities ≤0.3% 0.19% (RRT: 1.8)
  Total impurities ≤0.7% 0.29%
Heavy metal ≤20% <20%
Residue on ignition ≤0.2% 0.03%
Loss on drying ≤0.5% 0.04%
Assay ≥99.0% 99.4%
Conclusion Conforms with enterprise standards

Veterinary Medicine Api Enrofloxacin Soluble Powder 93106 60 6 HPLC Approved 0Veterinary Medicine Api Enrofloxacin Soluble Powder 93106 60 6 HPLC Approved 1

Contact Details
accenturebio3

Phone Number : 8618402999820

WhatsApp : +8618402999820